Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pembrolizumab and Azacitidine in Chemo-refractory Metastatic Colorectal Cancer
NCT02260440Phase 2Completed
- Sponsor
- Anuradha Krishnamurthy
- Start
- Jan 2015
- Primary completion
- Mar 2016
- Modality
- Immune Checkpoint Inhibitors, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of pembrolizumab in metastatic colorectal cancer (mCRC), sponsored by Anuradha Krishnamurthy. Started Jan 2015; status: completed.
02
Drugs
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT02260440.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02260440.